Effects of Lamotrigine on Behavioral and Cardiovascular Responses to Cocaine in Human Subjects

REFERENCES

• National Institute on Drug Abuse. Facts About Cocaine Abuse and Treatment. NIDA Notes 10(5), Author, Rockville, Maryland 1995
   Google Scholar
• Covi L., Montoya I. D., Hess J. M., et al. Desipramine for treatment of cocaine dependence: randomized, double-blind, placebo-controlled study. ACNP Ann. Meeting Abs. 1993; 173
   Google Scholar
• Covi L., Hess J. M., Kreiter N. A., et al. Desipramine and counselling for treatment of cocaine dependence: a controlled study. NIDA Res. Monogr. 1994; 153: 309
   Google Scholar
• Walsh S. L., Preston K. L., Sullivan J. T., et al. Fluoxetine alters the effects of intravenous cocaine in humans. J. Clin. Psychopharmacol. 1994; 14: 396–407
   PubMed Web of Science ®Google Scholar
• Walsh S. L., Sullivan J. T., Bigelow G. E. Fluoxetine effects on cocaine responses: a double-blind assessment. NIDA Res. Monogr. 1994; 153: 310
   Google Scholar
• Batki S. L., Washburn A. M., Delucchi K., et al. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend. 1996; 41: 137–142
   PubMed Web of Science ®Google Scholar
• Preston K. L., Sullivan J. T., Strain E. C., et al. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J. Pharmacol. Exp. Ther. 1992; 262: 279–291
   Google Scholar
• Weddington W. W., Brown B. S., Haertzen C. A., et al. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. NIDA Res. Monogr. 1989; 95: 483–484
   Google Scholar
• Alterman A. I., Droba M. Antelo, E. R., et al. Amantadine may facilitate detoxification of cocaine addicts. Drug Alcohol Depend. 1992; 31: 19–29
   PubMed Web of Science ®Google Scholar
• Margolin A., Kosten T. R., Avants S. K., et al. A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend. 1995; 40: 125–131
   PubMed Web of Science ®Google Scholar
• Sherer M. A., Kumor K. M., Jaffe J. H. Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Res. 1989; 27: 117–125
   PubMed Web of Science ®Google Scholar
• Stine S., Krystal J., Kosten T., et al. Mazindol treatment of cocaine abusers. ACNP Ann. Meeting Abs. 1992, 228
   Google Scholar
• Preston K. L., Sullivan J. T., Berger P., et al. Effects of cocaine alone and in combination with mazindol in human cocaine abusers. J. Pharmacol. Exp. Ther. 1993; 267: 296–307
   PubMed Web of Science ®Google Scholar
• Hatsukami D., Keenan R., Halikas J., et al. Effects of carbamazepine on acute responses to smoked cocaine-base in human cocaine users. Psychopharmacology 1991; 104: 120–124
   Google Scholar
• Halikas J. A., Crosby R. D., Pearson V. L., et al. A randomized double- blind study of carbamazepine in the treatment of cocaine abuse. Clin. Pharmacol. Ther. 1997; 62: 89–105
   PubMed Web of Science ®Google Scholar
• Montoya I. D., Levin F. R., Fudala P. J., et al. Double-blind study with carbamazepine for treatment of cocaine dependence. ACNP Ann. Meeting Abs. 1993, 173
   Google Scholar
• Kranzler H. R., Bauer L. O., Hersh D., et al. Carbamazepine treatment of cocaine dependence: a placebo-controlled trial [see comments]. Drug Alcohol Depend. 1995; 38: 203–311
   PubMed Web of Science ®Google Scholar
• Kosten T., Silverman D. G., Fleming J., et al. Intravenous cocaine challenges during naltrexone maintenance: a preliminary study. Biol. Psychiatry 1992; 32: 543–548
   PubMed Web of Science ®Google Scholar
• Carroll K., Ziedonis D., O'Malley S., et al. Pharmacologic interventions for abusers of alcohol and cocaine: disulfiram versus naltrexone. Am. J. Addict. 1993; 2: 77–79
   Google Scholar
• Hameedi F. A., Rosen M. I., McCance-Katz E. F., et al. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol. Psychiatry 1995; 37: 560–563
   PubMed Web of Science ®Google Scholar
• Pulvirenti L., Sung R., Koob G. F. Microinjection of NMDA but not quisqualate receptor antagonists into the nucleus accumbens modulates intravenous cocaine self-administration in rats. Soc. Neurosci. Abs. 1989; 15: 1098
   Google Scholar
• Pulvirenti L., Swerdlow N. R., Koob G. F. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol. Biochem. Behav. 1991; 40: 841–845
   Google Scholar
• Johnson M., Bush L. G., Gibb J. W., et al. Role of N-methyl-D-aspartate (NMDA) receptors in the response of extrapyramidal neurotensin and dynorphin A systems to cocaine and GBR 12909. Biochem. Pharmacol. 1991; 41: 649–652
   Google Scholar
• Torres G., Rivier C. Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists. Brain Res. Bull. 1993; 30: 173–176
   Google Scholar
• Rockhold R. W., Oden G., Ho I. K., et al. Glutamate receptor antagonists block cocaine-induced convulsions and death. Brain Res. Bull. 1991; 27: 721–723
   PubMedGoogle Scholar
• Witkin J. M., Tortella F. C. Modulators of N-methyl-D-aspartate protect against diazepam- or phenobarbital-resistant cocaine convulsions. Life Sci. 1991; 48: L51–L56
   Google Scholar
• Moghaddam B., Bolinao M. L. Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release. Synapse 1994; 18: 337–342
   PubMed Web of Science ®Google Scholar
• Pap A., Bradberry C. W. Excitatory amino acid antagonists attenuate the effects of cocaine on extracellular dopamine in the nucleus accumbens. J. Pharmacol. Exp. Ther. 1995; 274: 127–133
   PubMedGoogle Scholar
• Leach M. J., Marden C. M., Miller A. A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 1986; 27: 490–497
   PubMed Web of Science ®Google Scholar
• McGeer E. G., Zhu S. G. Lamotrigine protects against kainate but not ibotenate lesions in rat striatum. Neurosci. Lett. 1990; 112: 348–351
   PubMed Web of Science ®Google Scholar
• Margolin A., Avants S. K., DePhillips D., et al. A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. Am. J. Drug Alcohol Abuse 1998; 24: 85–101
   PubMed Web of Science ®Google Scholar
• Cohen A. F., Ashby L., Crowley D., et al. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br. J. Clin. Pharmacol. 1985; 20: 619–629
   PubMed Web of Science ®Google Scholar
• Van Dyke C., Ungerer J., Jatlow P., et al. Intranasal cocaine: dose relationships of psychological effects and plasma levels. Int. J. Psychiatry Med. 1982; 12: 1–13
   PubMedGoogle Scholar
• Fischman M. W., Schuster C. R. Cocaine effects in sleep-deprived humans. Psychopharmacology 1980; 72: 1–8
   PubMedGoogle Scholar
• McNair D. M., Lorr M., Droppleman L. F. Profile of Mood States (Manual). Educational and Industrial Testing Service, San Diego, California 1971
   Google Scholar
• Stevens J. Applied Multivariate Statistics for the Social Sciences. 2nd ed., Lawrence Erlbaum Associates, Hillsdale, , New Jersey 1992; 448
   Google Scholar
• Smith D., Baker G., Davies G., et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993; 34: 312–322
   PubMed Web of Science ®Google Scholar
• Smith D., Chadwick D., Baker G., et al. Seizure severity and the quality of life. Epilepsia 1993; 34: S31–S35
   Google Scholar
• Waldmeier P. C., Baumann P. A., Wicki P., et al. Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 1995; 45: 1907–1913
   PubMed Web of Science ®Google Scholar
• Rosen M. I., Pearsall H. R., Kosten T. R. The effect of lamotrigine on naloxone-precipitated opiate withdrawal. Drug Alcohol Depend. 1998; 52: 173–176
   PubMedGoogle Scholar
• Cone E. J. Pharmacokinetics and pharmacodynamics of cocaine. J. Anal. Toxicol. 1995; 19: 459–478
   PubMed Web of Science ®Google Scholar
• Shuaib A., Mahmood R. H., Wishart T., et al. Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioral study. Brain Res. 1995; 702: 199–206
   PubMedGoogle Scholar
• Crumrine C., Bergstrand K., Cooper A. T., et al. Lamotrigine prevents brain damage resulting from global ischemia caused by cardiac arrest with resuscitation. Soc. Neurosci. Abs. 1997; 23: 2433
   Google Scholar